Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation

The detection of circulating tumor DNA (ctDNA) in liquid biopsy samples as an oncological marker is being used in clinical trials at every step of clinical management. As ctDNA-based liquid biopsy kits are developed and used in clinics, companies work towards increased convenience, accuracy, and cos...

Full description

Bibliographic Details
Main Authors: Jonathan Dao, Patrick J. Conway, Baskaran Subramani, Devi Meyyappan, Sammy Russell, Daruka Mahadevan
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
liquid biopsy
cfDNA
ctDNA
Online Access:https://www.mdpi.com/1422-0067/24/17/13219

Similar Items

Similar Items